Abstract 1425MO
Background
The National Comprehensive Cancer Network (NCCN) Guidelines for Distress Management recommend that cancer patients should be promptly treated if the patient are distressed (more than 4 DT score). Numerous interventions, such as cognitive-behavioral therapy (CBT), relaxation, and psychosocial therapy, have been shown in randomized controlled trials to be efficacious in addressing distress in patients with cancer. However, many of these interventions have a low potential for implementation as part of routine care because of their complexity, the number of resources required to deliver them, and the limited range of distress-related problems they address. We aimed to evaluate whether psychosocial services for newly diagnosed distressed cancer patients would reduce the risk of 1 year mortality using real-world data.
Methods
We conducted a retrospective cohort study of 4,961 newly diagnosed cancer patients who underwent distress screening within three months after diagnosis and reported distress scores of 4 or higher between July 2014 and December 2017. For this study, it was considered that a patient used a psychosocial service if they had in-depth counseling by a social worker, visited the Supportive Care Center (SCC), or took any education program at the Cancer Education Center (CEC). The primary endpoint was all-cause mortality within one year until December 31, 2018.
Results
There were 18% had access to psychosocial services. During 4,652 person-years of follow-up, patients who used psychosocial services had a lower risk of 1-year mortality than those who did not (Hazard Ratio (HR) = 0.64; 95% CI = 0.47, 0.87). Among participants who used psychosocial services, the fully adjusted HR (95% CI) for 1-year mortality among participants who used psychosocial services within a month after distress screening was 0.52 (95% CI = 0.28, 0.98) compared to participants who used psychosocial services a month after screening. The association between psychosocial services and all-cause mortality was consistent between all subgroups analyzed.
Conclusions
This large real-world study suggests that timely psychosocial care would benefit newly diagnosed distressed cancer patients.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1554MO - Perspectives of patients with metastatic breast cancer on exercise interventions: Results from a survey in five European countries
Presenter: Maike Sweegers
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1555MO - Effects of exercise on sleep quality and cancer-related fatigue during neurotoxic chemotherapy
Presenter: Jana Müller
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
Invited Discussant 1425MO, 1554MO and 1555MO
Presenter: Antonio Di Meglio
Session: Mini Oral session: Supportive and palliative care
Resources:
Slides
Webcast
1556MO - The iBLAD study: Patient-reported outcomes in bladder cancer during oncological treatment: A multicenter national randomized controlled trial
Presenter: Gry Assam Taarnhøj
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1557MO - Phase II trial evaluating effect of gonyautoxins (GTX), a paralytic shellfish poisoning (PSP) on objective and subjective symptoms of chemotherapy-induced peripheral neuropathy (CIPN)
Presenter: Mariane Dias
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1558MO - Dissecting sexual health after breast cancer (BC) by longitudinal assessment of patient reported outcomes
Presenter: Maria Alice Franzoi
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
Invited Discussant 1556MO, 1557MO and 1558MO
Presenter: Maryam Lustberg
Session: Mini Oral session: Supportive and palliative care
Resources:
Slides
Webcast
LBA70 - COVID-19 in cancer patients: Update from the joint analysis of ESMO-CoCARE, BSMO, PSMO international databases
Presenter: Emanuela Romano
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1264MO - Development and validation of a unifying pre-treatment decision tool for intracranial and extracranial metastasis-directed radiotherapy
Presenter: Roman Kowalchuk
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1265MO - Cause and place of death in older patients with cancer: Results from a large cohort study using linked clinical and population-based data
Presenter: Victoria Depoorter
Session: Mini Oral session: Supportive and palliative care
Resources:
Abstract
Slides
Webcast